Author details

Full Name

Riyue Bao

Affiliation

UPMC Hillman Cancer Center

ORCID

Career Start Year

2007

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
36383142	Old Dog, New Trick: A Tumor-Intrinsic Role for PD-1 in Chemoresistant Tumor Subclones.	Clin Cancer Res	2023
37645831	Tumor cell p38 inhibition to overcome immunotherapy resistance.	Res Sq	2023
36550307	Treatment of peanut allergy and colitis in mice via the intestinal release of butyrate from polymeric micelles.	Nat Biomed Eng	2023
36892581	Randomized, Double-Blind, Placebo-Controlled Trial of MUC1 Peptide Vaccine for Prevention of Recurrent Colorectal Adenoma.	Clin Cancer Res	2023
34627858	Host-Microbiota Interactions in the Esophagus During Homeostasis and Allergic Inflammation.	Gastroenterology	2022
35705315	Wilms tumor reveals DNA repair gene hyperexpression is linked to lack of tumor immune infiltration.	J Immunother Cancer	2022
35135866	Next steps for clinical translation of adenosine pathway inhibition in cancer immunotherapy.	J Immunother Cancer	2022
33351788	Syngeneic tobacco carcinogen-induced mouse lung adenocarcinoma model exhibits PD-L1 expression and high tumor mutational burden.	JCI Insight	2021
33929266	Gestational sleep apnea perturbations induce metabolic disorders by divergent epigenomic regulation.	Epigenomics	2021
34921143	Investigating immune and non-immune cell interactions in head and neck tumors by single-cell RNA sequencing.	Nat Commun	2021
34392980	Absence of coding somatic single nucleotide variants within well-known candidate genes in late-onset sporadic Alzheimer's Disease based on the analysis of multi-omics data.	Neurobiol Aging	2021
34772919	Ionizing irradiation-induced Fgr in senescent cells mediates fibrosis.	Cell Death Discov	2021
34479957	Tumor Cell IDO Enhances Immune Suppression and Decreases Survival Independent of Tryptophan Metabolism in Glioblastoma.	Clin Cancer Res	2021
34326162	Overcoming PD-1 Blockade Resistance with CpG-A Toll-Like Receptor 9 Agonist Vidutolimod in Patients with Metastatic Melanoma.	Cancer Discov	2021
34272305	Immunogenomic determinants of tumor microenvironment correlate with superior survival in high-risk neuroblastoma.	J Immunother Cancer	2021
33945288	Pembrolizumab Plus Ipilimumab Following Anti-PD-1/L1 Failure in Melanoma.	J Clin Oncol	2021
33463536	Fecal microbiome and metabolome differ in healthy and food-allergic twins.	J Clin Invest	2021
33170593	Transcriptional analysis of metastatic uveal melanoma survival nominates NRP1 as a therapeutic target.	Melanoma Res	2021
33419763	Functional Common and Rare <i>ERBB2</i> Germline Variants Cooperate in Familial and Sporadic Cancer Susceptibility.	Cancer Prev Res (Phila)	2021
31558480	Randomized Phase II Trial and Tumor Mutational Spectrum Analysis from Cabozantinib versus Chemotherapy in Metastatic Uveal Melanoma (Alliance A091201).	Clin Cancer Res	2020
33083121	Genomic signatures of globally enhanced gene duplicate accumulation in the megadiverse higher Diptera fueling intralocus sexual conflict resolution.	PeerJ	2020
33106165	Molecular correlates and therapeutic targets in T cell-inflamed versus non-T cell-inflamed tumors across cancer types.	Genome Med	2020
33006642	Evolutionary conservation of opsin gene expression patterns in the compound eyes of darkling beetles.	Dev Genes Evol	2020
32675312	<i>ACE2</i> and <i>TMPRSS2</i> expression by clinical, HLA, immune, and microbial correlates across 34 human cancers and matched normal tissues: implications for SARS-CoV-2 COVID-19.	J Immunother Cancer	2020
32313567	Inhibition of the Wnt/Î²-catenin pathway enhances antitumor immunity in ovarian cancer.	Ther Adv Med Oncol	2020
32497898	WHSC1 monomethylates histone H1 and induces stem-cell like features in squamous cell carcinoma of the head and neck.	Neoplasia	2020
32487680	PD-1 Blockade in Chinese versus Western Patients with Melanoma.	Clin Cancer Res	2020
30635339	WNT/Î²-catenin Pathway Activation Correlates with Immune Exclusion across Human Cancers.	Clin Cancer Res	2019
31767020	BMI, irAE, and gene expression signatures associate with resistance to immune-checkpoint inhibition and outcomes in renal cell carcinoma.	J Transl Med	2019
31648992	Interferon-Î² corrects massive gene dysregulation in multiple sclerosis: Short-term and long-term effects on immune regulation and neuroprotection.	EBioMedicine	2019
31182433	Development and Validation of a Combined Hypoxia and Immune Prognostic Classifier for Head and Neck Cancer.	Clin Cancer Res	2019
31422218	Immune profiles in primary squamous cell carcinoma of the head and neck.	Oral Oncol	2019
31189592	Genome sequencing and transcriptome analyses of the Siberian hamster hypothalamus identify mechanisms for seasonal energy balance.	Proc Natl Acad Sci U S A	2019
30910787	<i>PD-L1</i> gene alterations identify a subset of diffuse large B-cell lymphoma harboring a T-cell-inflamed phenotype.	Blood	2019
30787124	Response to Anti-PD-1 in Uveal Melanoma Without High-Volume Liver Metastasis.	J Natl Compr Canc Netw	2019
30377198	Reimagining IDO Pathway Inhibition in Cancer Immunotherapy via Downstream Focus on the Tryptophan-Kynurenine-Aryl Hydrocarbon Axis.	Clin Cancer Res	2019
30643289	Healthy infants harbor intestinal bacteria that protect against food allergy.	Nat Med	2019
29302014	The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients.	Science	2018
30181337	T Cell-Inflamed versus Non-T Cell-Inflamed Tumors: A Conceptual Framework for Cancer Immunotherapy Drug Development and Combination Therapy Selection.	Cancer Immunol Res	2018
28928419	The histone deacetylase SIRT6 blocks myostatin expression and development of muscle atrophy.	Sci Rep	2017
28148567	Critical role of the cAMP-PKA pathway in hyperglycemia-induced epigenetic activation of fibrogenic program in the kidney.	FASEB J	2017
28442504	Characterization of the T-Cell Receptor Repertoire and Immune Microenvironment in Patients with Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck.	Clin Cancer Res	2017
28341751	Low Recombination Proficiency Score (RPS) Predicts Heightened Sensitivity to DNA-Damaging Chemotherapy in Breast Cancer.	Clin Cancer Res	2017
28090638	Late gestational intermittent hypoxia induces metabolic and epigenetic changes in male adult offspring mice.	J Physiol	2017
29435109	Clinical and molecular features of innate and acquired resistance to anti-PD-1/PD-L1 therapy in lung cancer.	Oncotarget	2017
29348866	Protein methyltransferases and demethylases dictate CD8+ T-cell exclusion in squamous cell carcinoma of the head and neck.	Oncotarget	2017
26923628	DNA Methylation Profiling of Blood Monocytes in Patients With Obesity Hypoventilation Syndrome: Effect of Positive Airway Pressure Treatment.	Chest	2016
26480299	Whole-exome Sequence Analysis Implicates Rare Il17REL Variants in Familial and Sporadic Inflammatory Bowel Disease.	Inflamm Bowel Dis	2016
27638840	Clinical Response of a Patient to Anti-PD-1 Immunotherapy and the Immune Landscape of Testicular Germ Cell Tumors.	Cancer Immunol Res	2016
27837020	Density of immunogenic antigens does not explain the presence or absence of the T-cell-inflamed tumor microenvironment in melanoma.	Proc Natl Acad Sci U S A	2016

1 - 50 of 72

Hailiang Mei

Leiden University Medical Center

Career Start Year 2014

Number of shared co-authors 0

Tuo Zhang

Weill Cornell Medical College.

Career Start Year 2013

Number of shared co-authors 0

Asha A Nair

Mayo Clinic

Career Start Year 2010

Number of shared co-authors 1

Kathleen M Fisch

Center for Computational Biology and Bioinformatics, University of California

Career Start Year 2009

Number of shared co-authors 3

Matti Nykter

Prostate Cancer Research Center, Tampere University and Tays Cancer Center

Career Start Year 2006

Number of shared co-authors 0

Christopher A Bristow

The University of Texas MD Anderson Cancer Center

Career Start Year 2005

Number of shared co-authors 7

Maggie Cam

Center for Cancer Research, National Cancer Institute, National Institutes of Health

Career Start Year 2005

Number of shared co-authors 0

Matthias Schlesner

University of Augsburg

Career Start Year 2004

Number of shared co-authors 3

Jianhua Zhang

University of Texas MD Anderson Cancer Center

Career Start Year 2003

Number of shared co-authors 7

Andrew V Kossenkov

The Wistar Institute

Career Start Year 2003

Number of shared co-authors 1

Jianmin Wang

Roswell Park Comprehensive Cancer Center

Career Start Year 2003

Number of shared co-authors 0

Amy G Robertson

Present address: Dxige Research Inc.

Career Start Year 2003

Number of shared co-authors 11

Olivier Elemento

Meyer Cancer Center

Career Start Year 2002

Number of shared co-authors 3

Michael Slifker

Fox Chase Cancer Center

Career Start Year 2002

Number of shared co-authors 0

Joel S Parker

Lineberger Cancer Center, University of North Carolina

Career Start Year 2002

Number of shared co-authors 11

Ludmila Danilova

Bloomberg-Kimmel Immunotherapy Institute, Johns Hopkins University School of Medicine

Career Start Year 2001

Number of shared co-authors 3

Sophia Derdak

Medical University of Vienna

Career Start Year 2001

Number of shared co-authors 1

Vladimir Makarov

Center for Immunotherapy and Precision-Immuno-Oncology, Cleveland Clinic

Career Start Year 2001

Number of shared co-authors 8

Mikhail G Dozmorov

Virginia Commonwealth University

Career Start Year 2001

Number of shared co-authors 1

David K Crossman

University of Alabama at Birmingham

Career Start Year 2000

Number of shared co-authors 1

Yan W Asmann

Mayo Clinic

Career Start Year 2000

Number of shared co-authors 1

Celine Lefebvre

The Scripps Research Institute

Career Start Year 1999

Number of shared co-authors 1

Shawn Levy

HudsonAlpha Institute for Biotechnology

Career Start Year 1999

Number of shared co-authors 6

Andrew J Gentles

Stanford Center for Biomedical Informatics Research, Stanford University

Career Start Year 1999

Number of shared co-authors 0

Benedikt Brors

German Cancer Research Center (DKFZ)

Career Start Year 1997

Number of shared co-authors 2

Lianbo Yu

The Ohio State University

Career Start Year 1997

Number of shared co-authors 0

Anamaria A Camargo

Hospital Sirio-Libanes

Career Start Year 1994

Number of shared co-authors 0

Luigi Marchionni

Weill-Cornell School of Medicine

Career Start Year 1989

Number of shared co-authors 2

Nir Hacohen

Broad Institute of MIT and Harvard

Career Start Year 1989

Number of shared co-authors 2

Sean Davis

Johns Hopkins School of Medicine, National Cancer Institute, Princeton University, University of Colorado Anschutz Medical Campus, University of Pittsburgh, University of Washington

Career Start Year 1974

Number of shared co-authors 7

row(s) 1 - 30 of 30